News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No market-moving news released in the past hour; major global equity indices showed little net change.
  • No new macroeconomic data or surprise releases were published this hour.
  • Central banks issued no statements or policy actions in the past hour.
  • No geopolitical developments reported this hour.
  • No corporate earnings surprises or takeover announcements emerged in the past hour.
  • Oil, gold and Treasury yields moved little this hour.

Latest Articles

ServiceTitan Report Finds Contractors Shifting Focus From AI Adoption to Implementation and Productivity

ServiceTitan Report Finds Contractors Shifting Focus From AI Adoption to Implementation and Productivity

ServiceTitan released its 2026 State of AI in the Trades report based on a survey of over 1,000 U.S. trades contractors, revealing a shift in focus from AI adoption to effective implementation and realizing measurable productivity benefits. While AI saves time for many contractors, challenges remain in translating efficiency into profitability and …

Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy

Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy

Nexalin Technology appoints Robert DiTota, a veteran neuromodulation executive with over two decades at Abbott and Medtronic, as Senior Strategic Advisor to guide its global commercialization strategy of the DIFS™ neurostimulation platform. The company is transitioning from clinical development to commercial sales in approved international markets …

Progress Software Launches ShareFile Enterprise, Offering a New Standard in Governance Controls for Enterprise Document Collaboration

Progress Software Launches ShareFile Enterprise, Offering a New Standard in Governance Controls for Enterprise Document Collaboration

Progress Software introduced ShareFile Enterprise, a new platform designed to help large and regulated organizations securely scale document collaboration. The offering provides automated access management, native data loss prevention, AI-driven threat detection, centralized security operations, and SOC-connected visibility, reducing administrative…

AMASS Electrolytes Achieves Approximately $1.4 Million Annualized Revenue Run Rate Four Months After Launch

AMASS Electrolytes Achieves Approximately $1.4 Million Annualized Revenue Run Rate Four Months After Launch

AMASS Brands Group announced that its new product line, AMASS Electrolytes, has reached an approximately $1.4 million annualized revenue run rate four months after its May 2026 launch. The sparkling mixers and hydration powders have shown rapid revenue growth, with September sales nearly double August's. The line is distributed across six key U.S. …

Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule

Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule

Liminatus Pharma announced it has regained compliance with Nasdaq’s minimum bid price rule after executing a 1-for-50 reverse stock split, resulting in its stock price remaining above $1.00 per share for over 13 consecutive trading days. This resolves the previous non-compliance issue and secures the company's continued listing on The Nasdaq Capita…

NeOnc’s Powerful Brain Cancer Pipeline Advances

NeOnc’s Powerful Brain Cancer Pipeline Advances

NeOnc Technologies Holdings (NASDAQ: NTHI) is preparing for a key FDA End-of-Phase 1 meeting on November 17, 2026, regarding its drug NEO212 for aggressive CNS cancers, aiming to refine Phase 2 trial plans and explore accelerated approval strategies. The company also reported promising Phase 2a results for its lead program NEO100 in glioma, demonst…

Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout

Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout

Moleculin Biotech announced the completion of enrollment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin combined with cytarabine in relapsed or refractory acute myeloid leukemia (AML). With 89 subjects enrolled, the company is on track for a comprehensive data readout in Q1 2027. The trial aims to assess efficacy across disti…

SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026

SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026

SeaStar Medical announced that its Chief Medical Officer, Dr. Kevin Chung, will deliver a presentation on the company's QUELIMMUNE® therapy at the 2026 Pediatric Paracorporeal and Extracorporeal Therapy Symposium. QUELIMMUNE is an FDA-approved selective cytopheretic device (SCD) therapy for critically ill pediatric patients with life-threatening ac…

Greenland Mines Brings Total New Capital to Over $59 Million with Above-Market Raise from Existing Shareholders

Greenland Mines Brings Total New Capital to Over $59 Million with Above-Market Raise from Existing Shareholders

Greenland Mines Ltd has raised more than $17 million through a registered direct offering at $13 per share, bringing total new capital raised in the past week to over $59 million. The funds will be used to finance exploration and development projects in Greenland, including rare earth and precious metals assets. The company also expanded its board …

MGPI: Cheap, Oversold Distillery Play with a Path to Recovery

MGPI: Cheap, Oversold Distillery Play with a Path to Recovery

MGP Ingredients (MGPI) looks like one of the cheapest names in the distressed distillery group: sub-$275M market cap, P/B ~0.46, and EV/EBITDA ~7.1. The stock is deeply oversold with an RSI near 21 and a 52-week low at $12.50. This trade targets a mid-term rebound while acknowledging material legal and demand risks that justify a tight stop and mod…

NaaS Technology Inc.'s Parent Company Named to 2026 China Top 100 Private Service Enterprises List, Highlighting AI-Driven Digital Energy Services

NaaS Technology Inc.'s Parent Company Named to 2026 China Top 100 Private Service Enterprises List, Highlighting AI-Driven Digital Energy Services

NaaS Technology Inc., a Nasdaq-listed EV charging service company in China and a subsidiary of Newlinks Technology Limited, announced that its parent company's subsidiary, Shandong Energy Chain Holding Co., Ltd., ranked 85th on the 2026 China Top 100 Private Service Enterprises list by the All-China Federation of Industry and Commerce. The recognit…

20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model

20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model

20/20 BioLabs announced an investor webinar on October 7, 2026, where CEO Jonathan Cohen will discuss the implications of the recent FDA advisory committee's favorable vote on multi-cancer early detection tests, the company’s new OneTest™ franchise model, preliminary laboratory interest across the U.S., and state funding for firefighter cancer scre…

Trident Digital Tech Holdings (Nasdaq: TDTH) Completes US$15 Million Equity Offering, Bringing September Financing to Approximately US$23 Million to Fund Execution of Its AI and Digital Infrastructure Strategy

Trident Digital Tech Holdings (Nasdaq: TDTH) Completes US$15 Million Equity Offering, Bringing September Financing to Approximately US$23 Million to Fund Execution of Its AI and Digital Infrastructure Strategy

Trident Digital Tech Holdings Ltd successfully completed an equity offering totaling approximately $23 million in September 2026 to fund its AI and digital infrastructure strategy. The entirely equity-based financing strengthens Trident's balance sheet without adding debt, following compliance restoration with Nasdaq listing requirements. The compa…

Host Digital Letter to Shareholders

Host Digital Letter to Shareholders

Host Digital Inc. CEO Harmol Samra addresses shareholders detailing the company's transition to a public entity and its focus on developing, owning, and operating RightScaled data centers (20 to 100 megawatts) with existing or near-term access to power tailored for AI and high-performance computing workloads. The letter highlights the signed 15-yea…

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered a 12-month agreement with Flash Sports & Media Holdings, Inc. (OTC: FLZH) to build and operate FlashChain, a blockchain dedicated to managing digital sports broadcasting rights, media assets, and ticketing inventory. MindWave …

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

TOMI Environmental Solutions announced new modular integration concepts for its SteraMist iHP platform targeting autonomous vehicles, drone fleets, and robotic systems. The company aims to embed automated disinfection into existing workflows in fleet depots, robotaxi networks, and other autonomous mobility operations to meet growing biosecurity nee…

Celularity Announces Naveen Jain to Join Board of Directors

Celularity Announces Naveen Jain to Join Board of Directors

Celularity Inc., a regenerative medicine company specializing in longevity and cell therapy, announced the appointment of Naveen Jain, founder and CEO of Viome Life Sciences, to its Board of Directors. Jain brings a consumer-focused healthcare perspective and expertise in emerging technologies aimed at personalized health. His addition supports Cel…

SAIC Wins U.S. Customs and Border Protection’s $742 Million Recompete Contract for Traveler and Cargo Security Systems

SAIC Wins U.S. Customs and Border Protection’s $742 Million Recompete Contract for Traveler and Cargo Security Systems

Science Applications International Corp. (SAIC) secured a $742 million recompete contract from U.S. Customs and Border Protection to provide comprehensive support for traveler and cargo security systems. The contract spans five years and reinforces SAIC's role in enhancing U.S. border security through technology integration and system upgrades. Add…

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific highlights progress in building a structured and scalable growth platform for its CompuFlo® medical business. The company is expanding physician adoption through its Advisor Program, securing Medicare reimbursement in key markets, broadening commercial coverage, and building clinical evidence to support broader utilization in m…